NVIDIA (NVDA) and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab ...

Nvidia Corp (NASDAQ: NVDA) and Eli Lilly and Co (NYSE: LLY) are launching a lab designed to apply advanced artificial intelligence to drug development. The collaboration will combine Lilly's expertise ...

Undergraduate students recently visited the SMU to aseptically manufacture lipid nanoparticles. Credit: Nathaniel Milton. WEST LAFAYETTE, Ind. — A mobile laboratory that Eli Lilly and Company used to ...

Corey Dambacher was working in Oregon when he discovered a type of ribonucleic acid capable of creating unique types of proteins that express themselves on the surfaces of cancer cells. It’s just the ...

Profluent and Lilly teamed up on AI‑designed enzymes in a deal worth up to $2.25B. Big tech, bigger gene edits.

Eli Lilly and Nvidia will launch a co-innovation AI lab to accelerate drug discovery. The companies will jointly invest up to $1 billion over five years to support the lab, which is based in the Bay ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact the technology sector. Nvidia (NVDA) and Eli Lilly (LLY) said they're investing up to $1B over five years to develop ...

Nvidia Corp. is partnering with Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies announced the collaboration today. They plan to ...

Nvidia Corp. (NVDA) and Eli Lilly (LLY) announced on Monday that the two companies will jointly invest $1 billion over five years to build a new joint research lab in the San Francisco Bay area. The ...

Eli Lilly and Co. and Purdue Strategic Ventures recently participated in a $12 million funding round to support a new remote lab platform aimed at significantly decreasing the time it takes to ...